Document is current
Any future updates will be listed below
-
Authors
Baglaenko, Yuriy https://orcid.org/0000-0002-9020-6824
Mu, Zepeng https://orcid.org/0000-0002-7717-3247
Curtis, Michelle https://orcid.org/0000-0002-6843-4839
Mire, Hafsa M.
Jayanthi, Vidyashree
Al Suqri, Majd https://orcid.org/0009-0006-8818-1329
Liu, Cassidy
Agnew, Ryan
Nathan, Aparna https://orcid.org/0000-0002-5975-2851
Mah-Som, Annelise Yoo
Liu, David R. https://orcid.org/0000-0002-9943-7557
Newby, Gregory A.
Raychaudhuri, Soumya https://orcid.org/0000-0002-1901-8265
- License Information
-
More Information
Article History
Received: 27 March 2024
Accepted: 20 June 2025
First Online: 23 July 2025
Competing interests
: S.R. is a founder of Mestag and an advisor to BMS, Janssen, Pfizer and Bonito Biosciences. D.R.L. is a co-founder of Beam Therapeutics, Prime Medicine, Pairwise Plants, Editas Medicine and nChroma Bio, which use or deliver genome-editing agents.
